Literature DB >> 31448657

Cytopathological Features of SMARCA4-Deficient Thoracic Sarcoma: Report of 2 Cases and Review of the Literature.

Maiko Takeda1, Yoko Tani1,2, Nobuhiko Saijo1, Shigeki Shimizu3, Yoshihiko Taniguchi1, Kenji Otsuka1,4, Keiko Nakao1, Akihiro Tamiya1, Kyoichi Okishio1, Shinji Atagi1, Chiho Ohbayashi5, Takahiko Kasai1.   

Abstract

SMARCA4-deficient thoracic sarcoma (SMARCA4-DTS) is a recently described entity of thoracic sarcomas with an undifferentiated rhabdoid morphology and SMARCA4 inactivation. Regardless of some reports about the histopathological findings so far, there have been only a few reports about the cytological features. In this article, we present the pathological features of 2 SMARCA4-DTS cases, including the cytological findings. Histopathologically, the tumor cells showed atypical loosely cohesive large epithelioid cells focally with geographic necrosis. Some cells were characterized by rhabdoid cells. Both patients showed intrathoracic masses with a history of smoking, and loss of SMARCA4 expression was confirmed with histopathological specimens. Immunohistochemically, tumor cells of both cases were at least focally positive for cytokeratin, CD34, CD99, synaptophysin, SOX2, and SALL4. In addition, tumor cells demonstrated significantly reduced expression of BRG1/SMARCA4 and SMARCA2. In conclusion, SMARCA4-DTS should be taken into consideration in the differential diagnosis of tumors with undifferentiated rhabdoid morphology involving the thoracic region.

Entities:  

Keywords:  SMARCA4-deficient thoracic sarcoma; SWI/SNF complex; immunohistochemistry; imprint cytology; rhabdoid cells

Mesh:

Substances:

Year:  2019        PMID: 31448657     DOI: 10.1177/1066896919870866

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  3 in total

1.  SMARCA4-deficient thoracic sarcoma revealed by metastasis to the small intestine: a diagnostic dilemma.

Authors:  Fatma Khanchel; Raweh Hedhili; Hakim Zenaidi; Imen Helal; Abdelwahed Yahmadi; Hend Ben Néji; Feryel Ksontini; Ehsen Ben Brahim; Raja Jouini; Aschraf Chadli
Journal:  Gen Thorac Cardiovasc Surg       Date:  2021-04-17

2.  Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study.

Authors:  Nina Anžič; Fatime Krasniqi; Anna-Lena Eberhardt; Alexandar Tzankov; Jasmin Dionne Haslbauer
Journal:  Case Rep Oncol       Date:  2021-05-10

3.  Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors.

Authors:  Justine Gantzer; Guillaume Davidson; Bujamin Vokshi; Noëlle Weingertner; Antoine Bougoüin; Marco Moreira; Véronique Lindner; Guillaume Lacroix; Céline Mascaux; Marie-Pierre Chenard; François Bertucci; Irwin Davidson; Jean-Emmanuel Kurtz; Catherine Sautès-Fridman; Wolf H Fridman; Gabriel G Malouf
Journal:  Oncologist       Date:  2022-06-08       Impact factor: 5.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.